Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Evaluation of Tumor-Stroma Ratio in Patients with Early Stage Cervical Adenocarcinoma Treated by Surgery

  • Published : 2015.06.03
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The tumor-stroma ratio (TSR) represents the percentage of neoplastic cell components compared to the combined area of neoplastic cells and the surrounding tumor-induced stroma. A low TSR (predomination of stromal component) has been demonstrated to be an independent adverse prognostic factor in cancers of several organs. In cervical carcinoma patients, TSR has been evaluated in only one previous study with different histological types. The present study aimed to assess the prognostic value of TSR in early stage cervical cancer patients with adenocarcinoma histology only. Materials and Methods: Histological slides of patients with early stage (IB-IIA) cervical adenocarcinoma who underwent surgical treatment between January 2003 and December 2011 were reviewed. Patients who had received preoperative chemotherapy were excluded. TSR was categorized as low (<50%) and high (${\geq}50%$). Correlations between TSR and clinicopathological variables were evaluated. Prognostic values of TSR and other variables were estimated using Cox's regression. Results: Of 131 patients; 38 (29.0%) had low TSR and 93 (71.0%) had high TSR. The patients with low TSR had significantly higher proportions of deep cervical stromal invasion (outer third of wall, p=0.011; residual stroma less than 3 mm, p=0.008) and parametrial involvement (p=0.026). Compared to the patients with high TSR, those with low TSR tended to have lower 5-year disease-free survival rate (83.8% versus 88.9%) and overall survival rate (85.6% versus 90.3%), although the differences were not statistically significant. Low TSR was significantly associated with decreased overall survival in univariate analysis (HR 2.7; 95% CI 1.0-7.0; p=0.041), but not in multivariate analysis. TSR was not significantly associated with decreased disease-free survival. Conclusions: Low TSR is associated with decreased overall survival in patients with early stage cervical adenocarcinoma treated by surgery. However, it was not found to be an independent prognostic predictor in this study.

Keywords

References

  1. Biewenga P, van der Velden J, Mol BW, et al (2011). Prognostic model for survival in patients with early stage cervical cancer. Cancer, 117, 768-76. https://doi.org/10.1002/cncr.25658
  2. de Kruijf EM, van Nes JG, van de Velde CJ, et al (2011). Tumorstroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat, 125, 687-96. https://doi.org/10.1007/s10549-010-0855-6
  3. De Wever O, Mareel M (2003). Role of tissue stroma in cancer cell invasion. J Pathol, 200, 429-47. https://doi.org/10.1002/path.1398
  4. Dekker TJ, van de Velde CJ, van Pelt GW, et al (2013). Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat, 139, 371-9. https://doi.org/10.1007/s10549-013-2571-5
  5. Diaz De Vivar A, Roma AA, Park KJ, et al (2013). Invasive endocervical adenocarcinoma: proposal for a new patternbased classification system with significant clinical implications: a multi-institutional study. Int J Gynecol Pathol, 32, 592-601. https://doi.org/10.1097/PGP.0b013e31829952c6
  6. Gien LT, Beauchemin MC, Thomas G (2010). Adenocarcinoma: a unique cervical cancer. Gynecol Oncol, 116, 140-6. https://doi.org/10.1016/j.ygyno.2009.09.040
  7. Hongladaromp W, Tantipalakorn C, Charoenkwan K, et al (2014). Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer. Asian Pac J Cancer Prev, 15, 887-90. https://doi.org/10.7314/APJCP.2014.15.2.887
  8. Intaraphet S, Kasatpibal N, Siriaunkgul S, et al (2013). Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma. Asian Pac J Cancer Prev, 14, 5355-60. https://doi.org/10.7314/APJCP.2013.14.9.5355
  9. Intaraphet S, Kasatpibal N, Sogaard M, et al (2014). Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma. Onco Targets Ther, 7, 1205-14.
  10. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  11. Kato T, Watari H, Takeda M, et al (2013). Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy. J Gynecol Oncol, 24, 222-8. https://doi.org/10.3802/jgo.2013.24.3.222
  12. Kawashiri S, Tanaka A, Noguchi N, et al (2009). Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck, 31, 1346-53. https://doi.org/10.1002/hed.21097
  13. Khunamornpong S, Lekawanvijit S, Settakorn J, et al (2014). Prognostic model in patients with early-stage squamous cell carcinoma of the uterine cervix: a combination of invasive margin pathological characteristics and lymphovascular space invasion. Asian Pac J Cancer Prev, 14, 6935-40.
  14. Khunamornpong S, Settakorn J, Sukpan K, et al (2013). Prognostic value of pathological characteristics of invasive margins in early-stage squamous cell carcinomas of the uterine cervix. Asian Pac J Cancer Prev, 14, 5165-9. https://doi.org/10.7314/APJCP.2013.14.9.5165
  15. Kim R, Emi M, Tanabe K (2007). Cancer immunoediting from immune surveillance to immune escape. Immunol, 121, 1-14. https://doi.org/10.1111/j.1365-2567.2007.02587.x
  16. Li H, Fan X, Houghton J (2007). Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem, 101, 805-15. https://doi.org/10.1002/jcb.21159
  17. Liu J, Li J, Chen Y, et al (2014). Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma. Gynecol Oncol, 132, 81-6. https://doi.org/10.1016/j.ygyno.2013.11.003
  18. Mesker WE, Junggeburt JM, Szuhai K, et al (2007). The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol, 29, 387-98.
  19. Obel J, Souares Y, Hoy D, et al (2014). A systematic review of cervical cancer incidence and mortality in the Pacific Region. Asian Pac J Cancer Prev, 15, 9433-7. https://doi.org/10.7314/APJCP.2014.15.21.9433
  20. Park JY, Kim DY, Kim JH, et al (2010). Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix. Br J Cancer, 102, 1692-8. https://doi.org/10.1038/sj.bjc.6605705
  21. Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, et al (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol, 18, 1606-13. https://doi.org/10.1200/JCO.2000.18.8.1606
  22. Pietras K, Ostman A (2010). Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res, 316, 1324-31. https://doi.org/10.1016/j.yexcr.2010.02.045
  23. Roma AA, Diaz De Vivar A, Park KJ, et al (2015). Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance. Am J Surg Pathol, [Epub ahead of print].
  24. Wang K, Ma W, Wang J, et al (2012). Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. J Thorac Oncol, 7, 1457-61. https://doi.org/10.1097/JTO.0b013e318260dfe8
  25. West NP, Dattani M, McShane P, et al (2010). The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer, 102, 1519-23. https://doi.org/10.1038/sj.bjc.6605674
  26. Zhu QC, Gao RY, Wu W, et al (2013). Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev, 14, 2689-98. https://doi.org/10.7314/APJCP.2013.14.5.2689

Cited by

  1. The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review pp.1573-7217, 2018, https://doi.org/10.1007/s10549-018-4987-4
  2. Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations vol.473, pp.4, 2018, https://doi.org/10.1007/s00428-018-2408-z
  3. The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact vol.73, pp.2, 2018, https://doi.org/10.1111/his.13489